Share Price and Basic Stock Data
Last Updated: October 29, 2025, 7:05 am
| PEG Ratio | 0.74 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Oriental Trimex Ltd operates within the granites and marbles industry, with a current market price of ₹9.70 and a market capitalization of ₹71.3 Cr. The company has experienced significant fluctuations in its revenue, recording total sales of ₹8.71 Cr for the fiscal year ending March 2023, which declined sharply to ₹3.65 Cr in March 2024. However, preliminary figures for March 2025 indicate a recovery with sales rising to ₹21.02 Cr and trailing twelve months (TTM) sales at ₹22.18 Cr. Quarterly sales data reveal a volatile trend, with sales dramatically falling to ₹0.10 Cr in September 2023 before rebounding to ₹16.66 Cr in March 2025. This inconsistency could be attributed to market demand variations and operational challenges, reflecting a need for strategic recalibration. The company’s ability to navigate these fluctuations will be crucial for future growth, particularly in a competitive sector where demand for high-quality granite and marble remains robust.
Profitability and Efficiency Metrics
Profitability metrics for Oriental Trimex Ltd indicate considerable challenges. The operating profit margin (OPM) stood at -42.94%, showcasing persistent operational inefficiencies. The company recorded a net profit of ₹8.68 Cr for the TTM, but this figure masks substantial losses in previous periods, including a net loss of ₹4.32 Cr in March 2023 and ₹6.50 Cr in March 2024. The return on equity (ROE) is reported at 7.12%, which is relatively low compared to sector averages, suggesting that shareholders are not realizing optimal returns on their investments. Additionally, the interest coverage ratio (ICR) is concerning, reported at -4.08x, indicating that the company is not generating sufficient earnings to cover its interest obligations. These profitability and efficiency metrics highlight the urgent need for Oriental Trimex to enhance operational processes and cost management to achieve sustainable profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Oriental Trimex Ltd reveals a cautious financial position, characterized by total borrowings of ₹2.29 Cr and reserves amounting to ₹24.49 Cr. The current ratio is reported at 3.90, suggesting a strong liquidity position, while the quick ratio stands at 3.07, indicating that the company can meet its short-term liabilities comfortably. The price-to-book value (P/BV) ratio is reported at 0.73x, which is below the typical sector range, reflecting potential undervaluation in the market. Furthermore, the total debt-to-equity ratio is remarkably low at 0.02, indicating minimal reliance on debt financing and a conservative capital structure. However, the company’s return on capital employed (ROCE) at 4.92% points to inefficiencies in generating returns from its capital. This combination of strong liquidity but low profitability could pose risks if not addressed promptly.
Shareholding Pattern and Investor Confidence
Oriental Trimex Ltd’s shareholding pattern reveals a dominant public ownership of 72.71%, with promoters holding 27.24% of shares. This distribution suggests a potential lack of institutional interest, as foreign institutional investors (FIIs) hold only 0.06% and domestic institutional investors (DIIs) have no significant stake in the company. The number of shareholders has increased significantly, from 14,399 in September 2022 to 47,340 in June 2025, indicating growing retail interest. However, the absence of institutional backing may reflect skepticism regarding the company’s growth prospects and operational efficiency. Investor confidence is critical, especially in a sector facing cyclical demand. The company must leverage this increased retail interest to improve fundamentals and potentially attract institutional investors in the future.
Outlook, Risks, and Final Insight
Moving forward, Oriental Trimex Ltd faces both opportunities and challenges. The recovery in sales for March 2025 presents a positive outlook, but persistent profitability issues, highlighted by low ROE and negative operating margins, remain significant risks. The company must focus on operational efficiency, cost management, and enhancing product offerings to capitalize on market demand. Additionally, the high cash conversion cycle of 689.55 days indicates inefficiencies in working capital management, which must be improved to strengthen cash flow. While the low debt levels provide a buffer against financial distress, the lack of institutional confidence could hinder growth if not addressed. If Oriental Trimex can successfully implement strategic changes to its operations and enhance profitability, it could leverage its market position to attract broader investor interest and achieve sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Oriental Trimex Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Inani Marbles & Industries Ltd | 35.9 Cr. | 19.3 | 32.4/14.4 | 299 | 28.8 | 0.21 % | 4.07 % | 1.27 % | 2.00 |
| Global Surfaces Ltd | 427 Cr. | 100 | 200/84.7 | 71.3 | 0.00 % | 1.97 % | 9.08 % | 10.0 | |
| Glittek Granites Ltd | 28.4 Cr. | 11.0 | 14.0/2.49 | 2.83 | 4.45 | 0.00 % | 115 % | 280 % | 5.00 |
| Elegant Marbles and Grani Industries Ltd | 84.6 Cr. | 231 | 299/205 | 18.3 | 397 | 0.43 % | 3.62 % | 2.93 % | 10.0 |
| Divyashakti Ltd | 61.1 Cr. | 59.5 | 83.1/55.0 | 18.9 | 193 | 3.36 % | 2.18 % | 1.58 % | 10.0 |
| Industry Average | 1,075.67 Cr | 142.32 | 73.99 | 170.92 | 0.37% | 15.18% | 30.50% | 8.09 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.00 | 3.34 | 3.24 | 0.13 | 0.32 | 0.10 | 0.21 | 3.01 | 0.54 | 1.94 | 1.88 | 16.66 | 1.70 |
| Expenses | 2.46 | 3.52 | 4.10 | 0.96 | 1.27 | -0.13 | 0.97 | 7.94 | 11.02 | 2.93 | 3.53 | 8.48 | 2.43 |
| Operating Profit | -0.46 | -0.18 | -0.86 | -0.83 | -0.95 | 0.23 | -0.76 | -4.93 | -10.48 | -0.99 | -1.65 | 8.18 | -0.73 |
| OPM % | -23.00% | -5.39% | -26.54% | -638.46% | -296.88% | 230.00% | -361.90% | -163.79% | -1,940.74% | -51.03% | -87.77% | 49.10% | -42.94% |
| Other Income | 0.21 | 0.04 | 0.00 | 0.00 | 1.45 | 0.35 | 0.02 | 0.89 | 11.26 | -0.34 | 7.00 | -0.24 | 1.81 |
| Interest | 1.52 | 0.06 | 0.06 | 0.07 | 0.06 | 0.06 | 0.07 | 1.59 | 0.00 | 0.82 | 0.04 | 0.14 | 0.07 |
| Depreciation | 0.37 | 0.00 | 0.73 | 0.37 | 0.37 | 0.37 | 0.37 | 0.36 | 0.14 | 0.17 | 0.12 | 0.13 | 0.21 |
| Profit before tax | -2.14 | -0.20 | -1.65 | -1.27 | 0.07 | 0.15 | -1.18 | -5.99 | 0.64 | -2.32 | 5.19 | 7.67 | 0.80 |
| Tax % | 0.00% | 0.00% | 0.00% | -73.23% | 0.00% | 0.00% | 0.00% | -7.35% | 26.56% | -7.33% | 17.92% | 22.16% | 26.25% |
| Net Profit | -2.13 | -0.20 | -1.65 | -0.34 | 0.07 | 0.16 | -1.17 | -5.56 | 0.48 | -2.15 | 4.26 | 5.97 | 0.60 |
| EPS in Rs | -0.30 | -0.03 | -0.22 | -0.05 | 0.01 | 0.02 | -0.16 | -0.76 | 0.07 | -0.29 | 0.58 | 0.81 | 0.08 |
Last Updated: August 1, 2025, 4:00 pm
Below is a detailed analysis of the quarterly data for Oriental Trimex Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 16.66 Cr. (Mar 2025) to 1.70 Cr., marking a decrease of 14.96 Cr..
- For Expenses, as of Jun 2025, the value is 2.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.48 Cr. (Mar 2025) to 2.43 Cr., marking a decrease of 6.05 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.73 Cr.. The value appears to be declining and may need further review. It has decreased from 8.18 Cr. (Mar 2025) to -0.73 Cr., marking a decrease of 8.91 Cr..
- For OPM %, as of Jun 2025, the value is -42.94%. The value appears to be declining and may need further review. It has decreased from 49.10% (Mar 2025) to -42.94%, marking a decrease of 92.04%.
- For Other Income, as of Jun 2025, the value is 1.81 Cr.. The value appears strong and on an upward trend. It has increased from -0.24 Cr. (Mar 2025) to 1.81 Cr., marking an increase of 2.05 Cr..
- For Interest, as of Jun 2025, the value is 0.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.14 Cr. (Mar 2025) to 0.07 Cr., marking a decrease of 0.07 Cr..
- For Depreciation, as of Jun 2025, the value is 0.21 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Mar 2025) to 0.21 Cr., marking an increase of 0.08 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.80 Cr.. The value appears to be declining and may need further review. It has decreased from 7.67 Cr. (Mar 2025) to 0.80 Cr., marking a decrease of 6.87 Cr..
- For Tax %, as of Jun 2025, the value is 26.25%. The value appears to be increasing, which may not be favorable. It has increased from 22.16% (Mar 2025) to 26.25%, marking an increase of 4.09%.
- For Net Profit, as of Jun 2025, the value is 0.60 Cr.. The value appears to be declining and may need further review. It has decreased from 5.97 Cr. (Mar 2025) to 0.60 Cr., marking a decrease of 5.37 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.08. The value appears to be declining and may need further review. It has decreased from 0.81 (Mar 2025) to 0.08, marking a decrease of 0.73.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:20 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 48.24 | 19.61 | 53.86 | 57.36 | 54.45 | 72.59 | 74.51 | 18.25 | 18.53 | 8.71 | 3.65 | 21.02 | 22.18 |
| Expenses | 51.84 | 26.16 | 55.18 | 55.63 | 48.74 | 67.52 | 66.04 | 16.86 | 19.04 | 11.03 | 10.03 | 25.95 | 17.37 |
| Operating Profit | -3.60 | -6.55 | -1.32 | 1.73 | 5.71 | 5.07 | 8.47 | 1.39 | -0.51 | -2.32 | -6.38 | -4.93 | 4.81 |
| OPM % | -7.46% | -33.40% | -2.45% | 3.02% | 10.49% | 6.98% | 11.37% | 7.62% | -2.75% | -26.64% | -174.79% | -23.45% | 21.69% |
| Other Income | 0.50 | 1.95 | 9.29 | 1.18 | -2.14 | -0.43 | 0.00 | 2.10 | 1.93 | 0.25 | 2.69 | 17.68 | 8.23 |
| Interest | 11.45 | 4.75 | 4.77 | 0.40 | 0.72 | 1.60 | 4.53 | 4.61 | 5.33 | 1.71 | 1.79 | 1.00 | 1.07 |
| Depreciation | 1.33 | 1.79 | 1.78 | 1.61 | 1.53 | 1.47 | 1.47 | 1.47 | 1.47 | 1.46 | 1.46 | 0.56 | 0.63 |
| Profit before tax | -15.88 | -11.14 | 1.42 | 0.90 | 1.32 | 1.57 | 2.47 | -2.59 | -5.38 | -5.24 | -6.94 | 11.19 | 11.34 |
| Tax % | -15.68% | 0.00% | 23.24% | 20.00% | -482.58% | 48.41% | 17.00% | 51.74% | 9.11% | -17.75% | -6.34% | 23.50% | |
| Net Profit | -13.39 | -11.14 | 1.10 | 0.72 | 7.68 | 0.82 | 2.05 | -3.92 | -5.87 | -4.32 | -6.50 | 8.57 | 8.68 |
| EPS in Rs | -3.62 | -3.01 | 0.30 | 0.19 | 1.29 | 0.12 | 0.29 | -0.55 | -0.82 | -0.59 | -0.88 | 1.17 | 1.18 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 16.80% | 109.87% | -34.55% | 966.67% | -89.32% | 150.00% | -291.22% | -49.74% | 26.41% | -50.46% | 231.85% |
| Change in YoY Net Profit Growth (%) | 0.00% | 93.07% | -144.42% | 1001.21% | -1055.99% | 239.32% | -441.22% | 241.47% | 76.15% | -76.87% | 282.31% |
Oriental Trimex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -22% |
| 3 Years: | 4% |
| TTM: | 475% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | % |
| 3 Years: | 1% |
| TTM: | 122% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 6% |
| 3 Years: | -7% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -7% |
| 3 Years: | -8% |
| Last Year: | -7% |
Last Updated: September 5, 2025, 12:00 pm
Balance Sheet
Last Updated: August 11, 2025, 2:29 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.82 | 14.82 | 14.82 | 14.82 | 23.82 | 28.52 | 28.52 | 28.52 | 28.52 | 29.40 | 29.40 | 73.51 |
| Reserves | 20.20 | 9.06 | 10.16 | 10.88 | 49.46 | 49.74 | 51.83 | 47.86 | 42.04 | 38.89 | 31.66 | 24.49 |
| Borrowings | 36.46 | 36.10 | 45.05 | 45.84 | 23.30 | 18.81 | 29.70 | 29.65 | 29.28 | 29.77 | 28.51 | 2.29 |
| Other Liabilities | 67.43 | 67.64 | 19.20 | 13.13 | 21.92 | 32.67 | 28.32 | 24.20 | 22.13 | 20.94 | 18.82 | 25.52 |
| Total Liabilities | 138.91 | 127.62 | 89.23 | 84.67 | 118.50 | 129.74 | 138.37 | 130.23 | 121.97 | 119.00 | 108.39 | 125.81 |
| Fixed Assets | 35.63 | 33.84 | 29.63 | 28.02 | 48.19 | 46.75 | 45.44 | 43.97 | 42.51 | 41.05 | 39.22 | 14.00 |
| CWIP | 0.06 | 0.06 | 0.06 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 103.22 | 93.72 | 59.54 | 56.59 | 70.31 | 82.99 | 92.93 | 86.26 | 79.46 | 77.95 | 69.17 | 111.81 |
| Total Assets | 138.91 | 127.62 | 89.23 | 84.67 | 118.50 | 129.74 | 138.37 | 130.23 | 121.97 | 119.00 | 108.39 | 125.81 |
Below is a detailed analysis of the balance sheet data for Oriental Trimex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 73.51 Cr.. The value appears strong and on an upward trend. It has increased from 29.40 Cr. (Mar 2024) to 73.51 Cr., marking an increase of 44.11 Cr..
- For Reserves, as of Mar 2025, the value is 24.49 Cr.. The value appears to be declining and may need further review. It has decreased from 31.66 Cr. (Mar 2024) to 24.49 Cr., marking a decrease of 7.17 Cr..
- For Borrowings, as of Mar 2025, the value is 2.29 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 28.51 Cr. (Mar 2024) to 2.29 Cr., marking a decrease of 26.22 Cr..
- For Other Liabilities, as of Mar 2025, the value is 25.52 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.82 Cr. (Mar 2024) to 25.52 Cr., marking an increase of 6.70 Cr..
- For Total Liabilities, as of Mar 2025, the value is 125.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 108.39 Cr. (Mar 2024) to 125.81 Cr., marking an increase of 17.42 Cr..
- For Fixed Assets, as of Mar 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 39.22 Cr. (Mar 2024) to 14.00 Cr., marking a decrease of 25.22 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 111.81 Cr.. The value appears strong and on an upward trend. It has increased from 69.17 Cr. (Mar 2024) to 111.81 Cr., marking an increase of 42.64 Cr..
- For Total Assets, as of Mar 2025, the value is 125.81 Cr.. The value appears strong and on an upward trend. It has increased from 108.39 Cr. (Mar 2024) to 125.81 Cr., marking an increase of 17.42 Cr..
Notably, the Reserves (24.49 Cr.) exceed the Borrowings (2.29 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -40.06 | -42.65 | -46.37 | -44.11 | -17.59 | -13.74 | -21.23 | -28.26 | -29.79 | -32.09 | -34.89 | -7.22 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 248.78 | 583.89 | 85.66 | 160.29 | 190.24 | 137.47 | 197.61 | 701.20 | 544.05 | 1,072.37 | 2,246.00 | 622.34 |
| Inventory Days | 475.16 | 923.35 | 281.38 | 157.27 | 170.47 | 218.02 | 219.13 | 925.27 | 785.87 | 1,312.71 | 1,182.46 | 411.83 |
| Days Payable | 49.86 | 37.35 | 35.12 | 23.31 | 74.89 | 117.62 | 109.13 | 272.40 | 74.21 | 46.95 | 84.43 | 344.62 |
| Cash Conversion Cycle | 674.08 | 1,469.89 | 331.92 | 294.25 | 285.82 | 237.88 | 307.61 | 1,354.07 | 1,255.71 | 2,338.13 | 3,344.03 | 689.55 |
| Working Capital Days | 100.63 | -4.84 | -12.13 | -20.43 | 136.21 | 163.92 | 227.98 | 552.40 | 469.00 | 899.72 | 1,566.00 | 1,305.28 |
| ROCE % | -4.75% | -7.80% | 4.80% | 2.54% | 6.80% | 6.27% | 8.04% | 1.89% | -0.05% | -3.57% | -6.40% | -4.92% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.52 | -2.36 | -1.78 | -1.88 | -1.37 |
| Diluted EPS (Rs.) | 1.52 | -2.65 | -1.65 | -1.88 | -1.37 |
| Cash EPS (Rs.) | 1.24 | -1.72 | -0.97 | -1.54 | -1.12 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 12.39 | 11.56 | 14.02 | 15.25 | 17.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 13.33 | 20.77 | 23.23 | 24.74 | 26.78 |
| Revenue From Operations / Share (Rs.) | 2.86 | 1.24 | 2.96 | 6.50 | 6.40 |
| PBDIT / Share (Rs.) | -0.55 | -1.55 | -0.70 | 0.49 | 0.97 |
| PBIT / Share (Rs.) | -0.63 | -2.04 | -1.20 | -0.01 | 0.71 |
| PBT / Share (Rs.) | 1.52 | -2.36 | -1.78 | -1.88 | -0.90 |
| Net Profit / Share (Rs.) | 1.17 | -2.21 | -1.47 | -2.06 | -1.38 |
| PBDIT Margin (%) | -19.50 | -124.70 | -23.75 | 7.67 | 15.18 |
| PBIT Margin (%) | -22.15 | -164.69 | -40.53 | -0.23 | 11.17 |
| PBT Margin (%) | 53.26 | -190.31 | -60.17 | -28.98 | -14.19 |
| Net Profit Margin (%) | 40.74 | -178.31 | -49.56 | -31.65 | -21.48 |
| Return on Networth / Equity (%) | 9.40 | -19.12 | -10.47 | -13.48 | -7.95 |
| Return on Capital Employeed (%) | -4.74 | -9.81 | -5.16 | -0.06 | 2.65 |
| Return On Assets (%) | 6.80 | -5.99 | -3.62 | -4.80 | -3.01 |
| Total Debt / Equity (X) | 0.02 | 0.19 | 0.15 | 0.13 | 0.12 |
| Asset Turnover Ratio (%) | 0.17 | 0.03 | 0.07 | 0.14 | 0.13 |
| Current Ratio (X) | 3.90 | 1.34 | 1.43 | 1.47 | 1.52 |
| Quick Ratio (X) | 3.07 | 0.76 | 0.74 | 0.73 | 0.81 |
| Inventory Turnover Ratio (X) | 0.83 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest Coverage Ratio (X) | -4.08 | -2.54 | -1.21 | 0.26 | 0.60 |
| Interest Coverage Ratio (Post Tax) (X) | -7.26 | -3.12 | -1.52 | -0.10 | 0.15 |
| Enterprise Value (Cr.) | 64.09 | 30.55 | 23.73 | 39.54 | 23.59 |
| EV / Net Operating Revenue (X) | 3.05 | 8.38 | 2.72 | 2.13 | 1.29 |
| EV / EBITDA (X) | -15.63 | -6.72 | -11.46 | 27.81 | 8.51 |
| MarketCap / Net Operating Revenue (X) | 3.19 | 6.71 | 2.04 | 1.82 | 0.96 |
| Price / BV (X) | 0.73 | 0.71 | 0.43 | 0.77 | 0.35 |
| Price / Net Operating Revenue (X) | 3.19 | 6.71 | 2.04 | 1.82 | 0.96 |
| EarningsYield | 0.12 | -0.26 | -0.24 | -0.17 | -0.22 |
After reviewing the key financial ratios for Oriental Trimex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.52. This value is below the healthy minimum of 5. It has increased from -2.36 (Mar 24) to 1.52, marking an increase of 3.88.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.52. This value is below the healthy minimum of 5. It has increased from -2.65 (Mar 24) to 1.52, marking an increase of 4.17.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.24. This value is below the healthy minimum of 3. It has increased from -1.72 (Mar 24) to 1.24, marking an increase of 2.96.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.39. It has increased from 11.56 (Mar 24) to 12.39, marking an increase of 0.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 13.33. It has decreased from 20.77 (Mar 24) to 13.33, marking a decrease of 7.44.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.86. It has increased from 1.24 (Mar 24) to 2.86, marking an increase of 1.62.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 2. It has increased from -1.55 (Mar 24) to -0.55, marking an increase of 1.00.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.63. This value is below the healthy minimum of 0. It has increased from -2.04 (Mar 24) to -0.63, marking an increase of 1.41.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.52. This value is within the healthy range. It has increased from -2.36 (Mar 24) to 1.52, marking an increase of 3.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 2. It has increased from -2.21 (Mar 24) to 1.17, marking an increase of 3.38.
- For PBDIT Margin (%), as of Mar 25, the value is -19.50. This value is below the healthy minimum of 10. It has increased from -124.70 (Mar 24) to -19.50, marking an increase of 105.20.
- For PBIT Margin (%), as of Mar 25, the value is -22.15. This value is below the healthy minimum of 10. It has increased from -164.69 (Mar 24) to -22.15, marking an increase of 142.54.
- For PBT Margin (%), as of Mar 25, the value is 53.26. This value is within the healthy range. It has increased from -190.31 (Mar 24) to 53.26, marking an increase of 243.57.
- For Net Profit Margin (%), as of Mar 25, the value is 40.74. This value exceeds the healthy maximum of 10. It has increased from -178.31 (Mar 24) to 40.74, marking an increase of 219.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.40. This value is below the healthy minimum of 15. It has increased from -19.12 (Mar 24) to 9.40, marking an increase of 28.52.
- For Return on Capital Employeed (%), as of Mar 25, the value is -4.74. This value is below the healthy minimum of 10. It has increased from -9.81 (Mar 24) to -4.74, marking an increase of 5.07.
- For Return On Assets (%), as of Mar 25, the value is 6.80. This value is within the healthy range. It has increased from -5.99 (Mar 24) to 6.80, marking an increase of 12.79.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.19 (Mar 24) to 0.02, marking a decrease of 0.17.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.17. It has increased from 0.03 (Mar 24) to 0.17, marking an increase of 0.14.
- For Current Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has increased from 1.34 (Mar 24) to 3.90, marking an increase of 2.56.
- For Quick Ratio (X), as of Mar 25, the value is 3.07. This value exceeds the healthy maximum of 2. It has increased from 0.76 (Mar 24) to 3.07, marking an increase of 2.31.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 4. It has increased from 0.01 (Mar 24) to 0.83, marking an increase of 0.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -4.08. This value is below the healthy minimum of 3. It has decreased from -2.54 (Mar 24) to -4.08, marking a decrease of 1.54.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -7.26. This value is below the healthy minimum of 3. It has decreased from -3.12 (Mar 24) to -7.26, marking a decrease of 4.14.
- For Enterprise Value (Cr.), as of Mar 25, the value is 64.09. It has increased from 30.55 (Mar 24) to 64.09, marking an increase of 33.54.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.05. This value exceeds the healthy maximum of 3. It has decreased from 8.38 (Mar 24) to 3.05, marking a decrease of 5.33.
- For EV / EBITDA (X), as of Mar 25, the value is -15.63. This value is below the healthy minimum of 5. It has decreased from -6.72 (Mar 24) to -15.63, marking a decrease of 8.91.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has decreased from 6.71 (Mar 24) to 3.19, marking a decrease of 3.52.
- For Price / BV (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.71 (Mar 24) to 0.73, marking an increase of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has decreased from 6.71 (Mar 24) to 3.19, marking a decrease of 3.52.
- For EarningsYield, as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. It has increased from -0.26 (Mar 24) to 0.12, marking an increase of 0.38.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Oriental Trimex Ltd:
- Net Profit Margin: 40.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -4.74% (Industry Average ROCE: 15.18%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.4% (Industry Average ROE: 30.5%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -7.26
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18.1 (Industry average Stock P/E: 73.99)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 40.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Granites/Marbles | 26/25, Bazar Marg, Old Rajinder Nagar, New Delhi Delhi 110060 | info@orientaltrimex.com http://www.orientaltrimex.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajesh Kumar Punia | Managing Director |
| Mrs. Savita Punia | Whole Time Director |
| Mr. Baldev Kumar Lakhanpal | Non Executive Director |
| Mr. Dinesh Narang | Ind. Non-Executive Director |
| Mr. Jayant Kumar | Ind. Non-Executive Director |
| Mr. Aditya Gupta | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Oriental Trimex Ltd?
Oriental Trimex Ltd's intrinsic value (as of 29 October 2025) is 13.99 which is 44.23% higher the current market price of 9.70, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 71.3 Cr. market cap, FY2025-2026 high/low of 17.6/8.32, reserves of ₹24.49 Cr, and liabilities of 125.81 Cr.
What is the Market Cap of Oriental Trimex Ltd?
The Market Cap of Oriental Trimex Ltd is 71.3 Cr..
What is the current Stock Price of Oriental Trimex Ltd as on 29 October 2025?
The current stock price of Oriental Trimex Ltd as on 29 October 2025 is 9.70.
What is the High / Low of Oriental Trimex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Oriental Trimex Ltd stocks is 17.6/8.32.
What is the Stock P/E of Oriental Trimex Ltd?
The Stock P/E of Oriental Trimex Ltd is 18.1.
What is the Book Value of Oriental Trimex Ltd?
The Book Value of Oriental Trimex Ltd is 13.3.
What is the Dividend Yield of Oriental Trimex Ltd?
The Dividend Yield of Oriental Trimex Ltd is 0.00 %.
What is the ROCE of Oriental Trimex Ltd?
The ROCE of Oriental Trimex Ltd is 4.92 %.
What is the ROE of Oriental Trimex Ltd?
The ROE of Oriental Trimex Ltd is 7.12 %.
What is the Face Value of Oriental Trimex Ltd?
The Face Value of Oriental Trimex Ltd is 10.0.